391 related articles for article (PubMed ID: 25527072)
41. Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands.
Jiang Y; Chen AC; Kuang GT; Wang SK; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2016 Oct; 122():264-279. PubMed ID: 27372288
[TBL] [Abstract][Full Text] [Related]
42. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
43. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
[TBL] [Abstract][Full Text] [Related]
44. Site-specific amino acid substitution in dodecameric peptides determines the stability and unfolding of c-MYC quadruplex promoting apoptosis in cancer cells.
Sengupta P; Banerjee N; Roychowdhury T; Dutta A; Chattopadhyay S; Chatterjee S
Nucleic Acids Res; 2018 Nov; 46(19):9932-9950. PubMed ID: 30239898
[TBL] [Abstract][Full Text] [Related]
45. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.
Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2011 May; 46(5):1906-13. PubMed ID: 21392861
[TBL] [Abstract][Full Text] [Related]
46. Fluorescent Dansyl-Guanosine Conjugates that Bind c-MYC Promoter G-Quadruplex and Downregulate c-MYC Expression.
Pavan Kumar Y; Saha P; Saha D; Bessi I; Schwalbe H; Chowdhury S; Dash J
Chembiochem; 2016 Mar; 17(5):388-93. PubMed ID: 26708259
[TBL] [Abstract][Full Text] [Related]
47. Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity.
Roy S; Ali A; Kamra M; Muniyappa K; Bhattacharya S
Eur J Med Chem; 2020 Jun; 195():112202. PubMed ID: 32302880
[TBL] [Abstract][Full Text] [Related]
48. Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence.
Di Leva FS; Zizza P; Cingolani C; D'Angelo C; Pagano B; Amato J; Salvati E; Sissi C; Pinato O; Marinelli L; Cavalli A; Cosconati S; Novellino E; Randazzo A; Biroccio A
J Med Chem; 2013 Dec; 56(23):9646-54. PubMed ID: 24256368
[TBL] [Abstract][Full Text] [Related]
49. FDA-approved drugs selected using virtual screening bind specifically to G-quadruplex DNA.
Castillo-González D; Pérez-Machado G; Guédin A; Mergny JL; Cabrera-Pérez MA
Curr Pharm Des; 2013; 19(12):2164-73. PubMed ID: 23016840
[TBL] [Abstract][Full Text] [Related]
50. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
51. Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22.
Scaglioni L; Mondelli R; Artali R; Sirtori FR; Mazzini S
Biochim Biophys Acta; 2016 Jun; 1860(6):1129-38. PubMed ID: 26922833
[TBL] [Abstract][Full Text] [Related]
52. Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization.
Rocca R; Moraca F; Costa G; Nadai M; Scalabrin M; Talarico C; Distinto S; Maccioni E; Ortuso F; Artese A; Alcaro S; Richter SN
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1329-1340. PubMed ID: 28025082
[TBL] [Abstract][Full Text] [Related]
53. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
Yin F; Liu J; Deng X; Wang J
J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
[TBL] [Abstract][Full Text] [Related]
54. Ruthenation of Non-stacked Guanines in DNA G-Quadruplex Structures: Enhancement of c-MYC Expression.
Rodríguez J; Mosquera J; Couceiro JR; Vázquez ME; Mascareñas JL
Angew Chem Int Ed Engl; 2016 Dec; 55(50):15615-15618. PubMed ID: 27860057
[TBL] [Abstract][Full Text] [Related]
55. Identification of a selective G-quadruplex DNA binder using a multistep virtual screening approach.
Hou JQ; Chen SB; Zan LP; Ou TM; Tan JH; Luyt LG; Huang ZS
Chem Commun (Camb); 2015 Jan; 51(1):198-201. PubMed ID: 25388435
[TBL] [Abstract][Full Text] [Related]
56. Spectroscopic studies of Thioflavin-T binding to c-Myc G-quadruplex DNA.
Verma S; Ghuge SA; Ravichandiran V; Ranjan N
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 212():388-395. PubMed ID: 30703662
[TBL] [Abstract][Full Text] [Related]
57. Spectroscopic probing of recognition of the G-quadruplex in c-kit promoter by small-molecule natural products.
Cui X; Lin S; Yuan G
Int J Biol Macromol; 2012 May; 50(4):996-1001. PubMed ID: 22405847
[TBL] [Abstract][Full Text] [Related]
58. Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules.
Pagano B; Amato J; Iaccarino N; Cingolani C; Zizza P; Biroccio A; Novellino E; Randazzo A
ChemMedChem; 2015 Apr; 10(4):640-9. PubMed ID: 25694275
[TBL] [Abstract][Full Text] [Related]
59. Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations.
Rocca R; Moraca F; Costa G; Alcaro S; Distinto S; Maccioni E; Ortuso F; Artese A; Parrotta L
Molecules; 2014 Dec; 20(1):206-23. PubMed ID: 25547724
[TBL] [Abstract][Full Text] [Related]
60. Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the
Han Y; Buric A; Chintareddy V; DeMoss M; Chen L; Dickerhoff J; De Dios R; Chand P; Riggs R; Yang D; Cushman M
J Med Chem; 2024 May; 67(9):7006-7032. PubMed ID: 38668707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
